Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Brain Tumor-Glioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00107237
What this trial is testing

AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Novartis Pharmaceuticals 16
Testing effectiveness (Phase 2)Study completedNCT00597402
What this trial is testing

Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas

Who this might be right for
GlioblastomaGliosarcomaBrain Tumor
Duke University 125
Very early researchNot Yet RecruitingNCT03763396
What this trial is testing

Azoles Targeting Recurrent High Grade Gliomas

Who this might be right for
Brain Tumor, RecurrentCancer, AdvancedGlioma of Brain
University Health Network, Toronto 30
Testing effectiveness (Phase 2)WithdrawnNCT02599090
What this trial is testing

Phase II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma

Who this might be right for
GlioblastomaGliosarcoma
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00352313
What this trial is testing

ATN-161 and Carboplatin in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Institutes of Health Clinical Center (CC) 82
Early research (Phase 1)Ended earlyNCT05627323
What this trial is testing

CAR T Cells in Patients With MMP2+ Recurrent or Progressive Glioblastoma

Who this might be right for
Glioblastoma Multiforme of Brain
Chimeric Therapeutics 1
Not applicableEnded earlyNCT03717142
What this trial is testing

Feasibility of the LUM Imaging System for Detection of Cancer to the Brain

Who this might be right for
Low Grade Glioma of BrainGlioblastomaMetastasis to Brain
Lumicell, Inc. 4
Not applicableStudy completedNCT03626896
What this trial is testing

Safety of BBB Disruption Using NaviFUS System in Recurrent Glioblastoma Multiforme (GBM) Patients

Who this might be right for
Glioblastoma MultiformeBrain TumorGlioblastoma+3 more
NaviFUS Corporation 6
Testing effectiveness (Phase 2)Study completedNCT00615927
What this trial is testing

Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG)

Who this might be right for
GlioblastomaGliosarcoma
Duke University 64
Testing effectiveness (Phase 2)WithdrawnNCT04737174
What this trial is testing

ES-481 for Uncontrolled Glioma-Associated Epilepsy and Assessment for Potential Anti-Tumorigenic Effect in Patients With Isocitrate Dehydrogenase 1 (IDH1) Mutant Tumors

Who this might be right for
Epilepsy; Seizure
ES Therapeutics Australia Pty Ltd
Testing effectiveness (Phase 2)Study completedNCT00302159
What this trial is testing

Valproic Acid With Temozolomide and Radiation Therapy to Treat Brain Tumors

Who this might be right for
High Grade GliomasBrain Tumors
National Cancer Institute (NCI) 43
Testing effectiveness (Phase 2)Study completedNCT00070161
What this trial is testing

Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor

Who this might be right for
Brain and Central Nervous System TumorsRadiation Toxicity
Wake Forest University Health Sciences 68
Not applicableUnknownNCT05397574
What this trial is testing

Intraoperative Hyperspectral Imaging for Fluorescence Guided Surgery in Low Grade Gliomas

Who this might be right for
NeurosurgeryNeuro-OncologyBrain Tumor
King's College London 60
Not applicableActive Not RecruitingNCT06649591
What this trial is testing

Expert Consensus and Artificial Intelligence in Medical Decision Making in Patients with Malignant Brain Tumors

Who this might be right for
Malignant Brain Tumors
Tufts Medical Center 225
Testing effectiveness (Phase 2)Active Not RecruitingNCT02691923
What this trial is testing

Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker

Who this might be right for
Brain Cancer
David W. Roberts 30
Early research (Phase 1)Ended earlyNCT01122888
What this trial is testing

Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+2 more
National Cancer Institute (NCI) 41
Not applicableWithdrawnNCT00005790
What this trial is testing

Perfusion Magnetic Resonance Imaging in Measuring the Growth of Blood Vessels in Newly Diagnosed Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Northwestern University
Early research (Phase 1)Ended earlyNCT02648633
What this trial is testing

Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent Glioblastoma

Who this might be right for
Glioblastoma
University of Virginia 4
Not applicableNo Longer AvailableNCT06439849
What this trial is testing

Single Patient Compassionate Use / Expanded Access L-S-Gboxin (Lyophilized Form of S-Gboxin) for the Treatment of Diffuse Midline Glioma

Who this might be right for
DIPG Brain TumorDiffuse Brainstem GliomaH3 K27M+2 more
Petrov, Andrey
Not applicableStudy completedNCT05015543
What this trial is testing

Physical Training in Glioblastoma Patients During Cytotoxic Therapy

Who this might be right for
Glioblastoma
University Hospital Muenster 54
Next Page